CAR-T cell therapy can be great, but.. the T cells express PD1 and get exhausted. Check out this #GIF I made for a recent @jitcancer paper on this topic (bit.ly/35G8na3)
___
#cancer #immunotherapy #AcademicChatter #AcademicTwitter #scicomm (credit: @Biorender)
Just like people, T cells get exhausted. Taking a break helps!
Here, the authors developed a SNIP CAR - “a protease-based platform for regulating CAR activity using an FDA-approved small molecule”, which showed diminished T cell exhaustion bit.ly/3LgUqUr
#Immunotherapy
How can regulatory T cells (Tregs) be depleted in cancer?
In this recent paper in @ScienceTM, the authors show how dual targeting of CTLA4 and CD47 on Tregs is effective. bit.ly/3yT5DWd
#AcademicTwitter #Immunotherapy @UTSWNews
What’s happening with CAR-T cells and beyond in cancer?
This nice review summarizes recent advances and efforts to leverage T cells and NK cells. nature.com/articles/s41423-0…
#Immunotherapy #AcademicTwitter
Can pre-treatment with targeted therapy influence response to subsequent immunotherapy?
Here, they show that "when tumors relapse after anti-MAPK targeted therapy, they are cross-resistant to immunotherapies". nature.com/articles/s43018-0…
#Immunotherapy @NatureCancer
Can immunotherapy provide long-term responses?
Median survival (months) for metastatic melanoma was reported at ASCO for:
CTLA4 + PD1 👉 72.1
PD1 👉 36.9
CTLA4 👉 19.9
#AcademicTwitter #cancer #Immunotherapy @ASCOPost
ascopost.com/news/june-2021/…
Predicting response to immunotherapy is important, but what’s a good marker?
Here they show how TCR clonality of tumor-infiltrating T cells predict anti-PD1 efficacy: nature.com/articles/s41467-0…
#AcademicTwitter #cancer #immunotherapy @NatureComms
Does tumor location/tissue site matter?
Here they show how the same tumor cell line display different take rates, immune infiltration, and response to immunotherapy depending on where the tumor grows. cancerimmunolres.aacrjournal…
#AcademicTwitter #cancer #Immunotherapy @CIR_AACR
How do tumor cells survive in the circulation?
This recent paper highlights the importance of CCL5 as a mediator of immune evasion. nature.com/articles/s41467-0…
#AcademicTwitter #cancer @NatureComms
Replying to @Tcellogic @patrickreville
Such clever and beautiful illustration👏🏻
When to give immunotherapy?
Giving anti-CTLA4 BEFORE anti-PD1 was found to be superior in this recent paper: go.nature.com/3w43rZL
#AcademicTwitter #Immunotherapy @NatImmunol @ljiresearch
Who will respond to immunotherapy?
This recent paper suggests that the tumor microenvironment falls into 4 categories and can predict therapeutic response: bit.ly/3wQDcXR #AcademicTwitter @MDAndersonNews @BostonGeneCorp
Cool new finding and beautiful images when researchers identify "a link between sensory neurons activation and the immune system". #AcademicTwitter #phdchat
medicalxpress.com/news/2020-…
Patrik Andersson retweeted
Send a picture of something that shows very clearly you are a Grad/Undergrad student! This is mine 🤣
#phdchat @AcademicChatter @OpenAcademics @PhDVoice
Repurposing of drugs for cancer is already a popular strategy. Should all drugs, within reason, that have passed toxicity studies in any indication, be tested in preclinical models of cancer in a high-throughput manner? #AcademicTwitter
Just me having too much fun editing this video! Tell me more about you #phdchat #phdlife #postdoc #academictwitter
Patrik Andersson retweeted
Let me know if you have entered this graphical abstract contest at @BioRender - I would love to share yours❤️
#AcademicTwitter #phdchat #scicomm biorender.com/graphical-abst…
It really hits me hard seeing young people die in cancer. Moments of feeling hopeless is exchanged with motivation. Motivation to do better, to contribute to better therapies.
What's your motivation? #AcademicTwitter #cancer #phdchat #beatcancer
Making friends with scorpions? 🦂
Enter this competition at @BioRender or just vote for my contribution 😃 #AcademicTwitter #sciencetwitter #phdchat #scicomm #cancer #Immunity #scicomm
Link: app.biorender.com/contest/ga…














